For example, PRAJA2 might underlie the association of ARHGAP36 with Hh pathway-independent medulloblastoma subtypes, neuroblastoma, and/or endocrine cancers [1, 7, 8, 17–19]. Here, ARHGAP36 is linked to malignant endocrine neoplasm.